Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Richard De Vuyst
Observed names:
R. De Vuyst,
R.C. De Vuyst,
Richard C. De Vuyst
Institutions:
University of Oklahoma Health Sciences Center,
University of Oklahoma
Observed institutions:
University of North Carolina at Chapel Hill,
University of Oklahoma Health Sciences Center,
University of Oklahoma
ORCID:
0000-0002-1561-8546
Observed ORCID:
0000-0002-1561-8546
OpenAlex ID:
A5084107923
Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis
2023
·
Richard C. De Vuyst
, Erin Bennard
, et al.
·
Pediatric Pulmonology
·
21
PDF
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor
2024
·
Richard De Vuyst
, Charissa W. Kam
, et al.
·
Pediatric Pulmonology
·
12
PDF
Airway Findings in Patients with Hunter Syndrome Treated with Intravenous Idursulfase
2023
·
Richard De Vuyst
, Elizabeth Jalazo
, et al.
·
Journal of Clinical Medicine
·
2
PDF
A Case of Cystic Fibrosis in a Child With Speech Apraxia
2024
·
M.C. Farrell
, R.C. De Vuyst
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
Poster: 401Transition in action: Re-launching CF RISE to empower adolescents with cystic fibrosis
2026
·
B. Maxey
, N. Mehdi
, et al.
·
Journal of Cystic Fibrosis
Poster: 551Factors predicting return of pancreatic exocrine function in people with cystic fibrosis
2026
·
J. Dannelley
, A. Sanders
, et al.
·
Journal of Cystic Fibrosis
486 Engaging the CF care team through re-establishing a routine team meeting structure
2024
·
J. Dannelley
, J. Dorris
, et al.
·
Journal of Cystic Fibrosis
An Unusual Case of Aspiration Pneumonitis Due to CSF Aspiration
2023
·
S. Hendricks
, R. De Vuyst
, et al.
·
American Journal of Respiratory and Critical Care Medicine
219 Changes in the relationship between body mass index and forced expiratory volume in 1 second after initiation of elexacaftor/tezacaftor/ivacaftor therapy
2022
·
C. Kam
, C. McKinzie
, et al.
·
Journal of Cystic Fibrosis
PDF
49 Medication adherence and lung function changes with elexacaftor/tezacaftor/ivacaftor treatment
2022
·
C. Esther
, R. De Vuyst
, et al.
·
Journal of Cystic Fibrosis
PDF
444 Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis
2022
·
R. De Vuyst
, C. Kam
, et al.
·
Journal of Cystic Fibrosis
PDF
Show more works
View as search
Works count:
11
Citation count:
36
H-index:
2
I10-index:
2
Year
Topic
Type